Acceptability and Efficacy of Remote Treatment for Social Anxiety Disorder

Not Applicable

Recruiting

• Conditions: Social Anxiety Disorder; Mental Health - Anxiety

• Registration Number: ACTRN12623000313639
• Lead Sponsor: niversity of Technology Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-03-22
• Last Update Posted: 8 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 78

Inclusion Criteria

1. Currently resides in Australia
2. Aged 18+ years
3. Fluent in English
4. Meets criteria for social anxiety disorder as primary diagnosis and the disorder is of at least 'moderate severity' (defined as a score of 4 on the DIAMOND module severity measure (Tolin et al., 2018))
5. Medication free or on a stable dose of psychotropic medication
6. Not currently receiving regular psychological services for their social anxiety symptoms (defined as sessions at least once a week with a qualified mental health professional)

Exclusion Criteria

1. Severe depressive symptoms as assessed by a score of 20 or above on the PHQ-9
2. Are at suicide risk by a score of 2 (more than half the days) or higher on item 9 of the PHQ-9 on the screening questions or via clinician judgement during the interview using the Columbia-Suicide Severity Rating Scale (C-SSRS)
3. Engage in daily alcohol use or daily illicit drug use
4. Presence of schizophrenia spectrum disorder as assessed by the DIAMOND
5. Significant cognitive/intellectual impairment as assessed during the diagnostic interview
6. A medical condition that may interfere with treatment
7. Does not have access to a computer with a camera and stable internet on a regular basis
8. Is not willing to engage in treatment via internet videoconferencing software

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Social anxiety disorder symptom severity will be measured with the Social Interaction Anxiety Scale-Short Form (SIAS-6) (Mattick & Clarke, 1998)[ Baseline<br>Mid-treatment (week 4)<br>Post treatment (week 9, primary endpoint)<br>3-month follow-up post treatment completion];Social anxiety disorder symptom severity will be measured with the Social Phobia Scale-Short Form (SPS) (Mattick & Clarke, 1998)[ Baseline<br>Mid-treatment (week 4)<br>Post treatment (week 9, primary endpoint)<br>3-month follow-up post treatment completion];Acceptability will be measured with the Client Satisfaction Questionnaire (CSQ) (Attkisson & Zwick, 1982)[ Mid-treatment (week 4)<br>Post treatment (week 9, primary endpoint)]